Nexalin technology secures uspto patent for deep intracranial frequency stimulation (difs™) technology in treating substance use disorders

Patent approval reinforces nexalin's leadership in non-invasive brain stimulation for addiction treatment patent approval reinforces nexalin's leadership in non-invasive brain stimulation for addiction treatment

NXL Ratings Summary

NXL Quant Ranking